Status:
UNKNOWN
"Gait and Balance in Patients With SCFE"
Lead Sponsor:
Maastricht University Medical Center
Conditions:
Slipped Capital Femoral Epiphyses
Eligibility:
All Genders
8-21 years
Brief Summary
Slipped Capital Femoral Epiphysis (SCFE) treated with one screw in situ fixation results in an altered gait. It is thought that the protraction of the pelvis at the affected side, seen in patients wit...
Detailed Description
Rationale: Slipped Capital Femoral Epiphysis (SCFE) treated with one screw in situ fixation results in an altered gait. It is thought that the protraction of the pelvis at the affected side, seen in p...
Eligibility Criteria
Inclusion
- Aged between 8 and 21 years.
- Unilateral stable SCFE, with clinical and radiological confirmation and lateral slip angles ranging from mild (LSA \<30°), moderate (LSA 30°-50°) to severe (LSA \>50°) based on the method of Southwick.
- Treatment of the slip with single screw in situ fixation in the last ten years, with no evidence of major complications related to the procedure like chondrolysis, avascular necrosis and infection or slip progression. Follow up at our institution for at least one year.
- Ability to walk 30 minutes without aid.
- Is able to speak, read and write the Dutch language
Exclusion
- Clinical or radiological evidence of a contralateral slip or an endocrinopathy as underlying cause of SCFE.
- Revision surgery.
- Other pathology leading to gait alterations.
Key Trial Info
Start Date :
December 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT03326531
Start Date
December 1 2017
End Date
December 1 2021
Last Update
January 17 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht University Medical Centre
Maastricht, Limburg, Netherlands, 6202AZ